Ticagrelor Ticagrelor Ticagrelor (trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor produced by AstraZeneca. Ticagrelor is an antagonist of the P2Y receptor. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011. Ticagrelor is used for the prevention of thrombotic events (for example stroke or heart attack) in people with acute coronary syndrome or myocardial infarction with ST elevation. The drug is combined with acetylsalicylic acid unless the latter is contraindicated. There is no high
Erucic acid surfactants or lubricants, and can be used as a precursor to biodiesel fuel. Derivatives of erucic acid have many further uses, such as behenyl alcohol (CH(CH)OH), a pour point depressant (enabling liquids to flow at a lower temperature), and silver behenate, for use in photography. The name 'erucic' means: of or pertaining to "Eruca"; which is a genus of flowering plants in the family Brassicaceae. It is also the Latin for colewort, which today is better known as arugula. Erucic acid is produced naturally (together with other fatty acids) across a great range of green plants, but especially so in